பள்ளி ஆஃப் ப்யாகேஜிஂக் இல் மிச்சிகன் நிலை பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This article was originally published on The Conversation. Bahar Aliakbarian is an expert in supply chain management in pharmaceuticals and a professor at the School of Packaging at Michigan State University. Below, she describes the vaccine supply chains of Pfizer and Moderna, which are expected to be the two major early suppliers of the COVID-19 vaccines in the U.S. She also talks about challenges in distribution and the work being done to ensure safe and systematic delivery of the vaccines. What are the main challenges in distributing the newly developed COVID-19 vaccines? Advertisement: The two major U.S. developers of the early COVID-19 vaccines are Pfizer/BioNTech and Moderna. They both developed mRNA vaccines, a relatively new type of vaccine. A major supply chain issue is the temperature requirement for these vaccines. The Pfizer vaccine needs to be stored at between minus 112 F (minus 80 C) and minus 94 F (minus 70 C), and the Moderna vaccine needs temperatures around mi

New yorkUnited statesMichigan state universityBahar aliakbarianCenters for diseaseSchool of packaging at michigan state universityAviation administrationMichigan stateOperation warpFederal aviation administrationDisease controlCreative commonsபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்மிச்சிகன் நிலை பல்கலைக்கழகம்மையங்கள் க்கு நோய்